Monoclonal antibodies (MAbs) against a nonencapsulated strain (R36A) of Streptococcus pneumoniae were produced to aid in a search for antigens common to this species. By Western immunoblot analysis, a species-specific 37-kilodalton (kDa) protein was found in lysates of 24 different encapsulated strains of S. pneumoniae. Monoclonal antibodies against the 37-kDa antigen did not react with 55 heterologous strains representing 19 genera and 36 species of bacteria that can also cause acute lower respiratory tract disease.
Disease caused by Streptococcus pneumoniae (pneumococcus) is an important cause of morbidity and mortality in the United States and developing countries (37, 40, 41, 44) . Pneumococcus disease is very prevalent among the very young, the elderly, and immunocompromised persons. Despite its prevalence, diagnosis of the disease continues to be a problem.
Several tests have been developed to detect pneumococcus antigens and/or antibodies as a means of diagnosing pneumococcus infections (12, 18, 21, 22, 25, 28, 33, 36, 43, 45) . The sensitivity of existing antigen detection tests utilizing body fluids such as serum and urine remains very low (1, 2, 7, 10, 11, 13, 14, 16, 30) , except for antigen detection in cerebrospinal fluids (17, 21, 27, 38, 45) . The measurement of antibody response to pneumolysin by enzyme-linked immunosorbent assay (ELISA) appears to be promising for presumptive etiologic diagnosis (22, 23, 25) , but the sensitivity and specificity of the test need improvement.
Although a positive blood culture is diagnostic for pneumococcus disease, most patients with bacterial pneumonia do not have bacteremia (3, 4, 24) . The value of sputum cultures has also been questioned because of contamination of the specimens with pharyngeal flora that can include pneumococci (6) . Thus, clinical laboratories are rarely successful in establishing a firm bacterial etiology for those patients with respiratory infections diagnosed presumptively as pneumococcus pneumonia. Researchers have been in constant search of immunodiagnostic markers or tests to aid in the early diagnosis of pneumococcus infections. In this report, we describe the production and characterization of monoclonal antibodies (MAbs) that react with a speciesspecific antigen found in S. pneumoniae. We assessed the sensitivity and specificity of the MAbs and the antigens to which they bind as a means of determining their usefulness as immunodiagnostic markers for the etiologic diagnosis of pneumococcal infection. * Corresponding author. 25 by using standard procedures (9) . Spleen cells of four mice were fused with Sp2/0-Agl4 myeloma cells (35) . Culture fluids of the growing hybridomas were tested for antibodies to S. pneumoniae whole cells in an ELISA. A clone designated lE7A3D7C2 was one of 10 selected for further study. Further references to MAbs in this article refer to hybridoma clone lE7A3D7C2.
ELISA. Screening of hybridoma culture supernatants was done by ELISA. U-bottom microtitration plates (Costar, Cambridge, Mass.) were sensitized with 50 p1 of S. pneumoniae whole-cell suspension (109 CFU/ml) diluted 1:4,000 in 0.1 M carbonate buffer, pH 9.6, and kept for 16 h at 4°C. The plates were washed five times with 0.9% NaCI containing 0.05% Tween 20 (NaCI-T). Culture supernatants (50 pul) from the fusion plates were added to 50 pli of a solution containing 2% bovine serum albumin (BSA), 10% normal rabbit serum, 0.3% Tween 20, and 0.02% Merthiolate in phosphate-buffered saline (PBS), pH 7.2 (ELISA diluent) (42) , in the plates and were incubated for 30 min at 37°C. The plates were washed five times with NaCl-T. Fifty microliters of goat anti-mouse immunoglobulin horseradish peroxidase conjugate, prepared by one of us (D. E. Wells), diluted in ELISA diluent`was added to each well. The plates were incubated for 30 min at 37°C. The plates were washed, and 50 pil of 3,3',5,5'-tetramethylbenzidine (0.1 mg/ml in 0. (26) . After three rinses with CTB, the blots were exposed to MAbs diluted in CTB for 2 h at 25°C. After three rinses with CTB, the blots were exposed to goat anti-mouse immunoglobulin horseradish peroxidase conjugate (Bio-Rad Laboratories, Richmond, Calif.) for 2 h at 25°C. Conjugate dilutions (1:2,000) were made in CTB. The blots were again rinsed three times with CTB and exposed to 3-3'-diaminobenzidine-4-hydrochloride in PBS, pH 7.2 (0.5 mg/ml), with 0.003% H202 for 5 min at 25°C. Reactivity was expressed as a visible colored band on the nitrocellulose paper.
Low-molecular-mass protein standards (Bio-Rad) were used in PAGE and immunoblotting. Rabbit antisera to the protein standards were used to develop the standards (8 reacted with all pneumococcal strains tested (24 serotypes) to yield a sensitivity of 100%. For specificity, 55 different nonpneumococcus strains of bacteria that can also cause respiratory infections (15) were tested for antigens reacting with the MAbs. The latter strains represented 19 genera and 36 species of bacteria. None of the strains tested reacted with the pneumococcal MAbs, thus yielding a specificity of 100%.
Western blots with human sera. Of 44 patients known to have pneumococcus disease, 34 (77%) had antibodies that reacted with the 37-kDa antigen by Western immunoblot (Fig. 1) .
Reactivity of MAbs in the ELISA and IFA. MAbs reacted with whole pneumococcus cells to yield positive test results in both the ELISA and IFA. Figure 2 shows the bright immunofluorescence of whole pneumococcus cells stained by the MAbs and fluorescein-labeled anti-mouse immunoglobulin in the IFA. Results from both the ELISA and the IFA indicate that the antigen has exposed epitopes on the surface of the cell or that the immunoglobulin and other immunologic reagents are able to penetrate the pneumococcus cell walls.
Several strains of group A streptococci were tested for immunofluorescence after reacting with the pneumococcus MAbs. None of the heterologous bacterial cells fluoresced in this test, indicating that the IFA reaction was specific for pneumococcus cells.
Localization of antigen determined by transmission electron microscopy. To further determine the location on the cell of the 37-kDa antigen epitopes reacting with the MAbs, immunolabeling experiments were performed. Figure 3 shows that the cells were typical of gram-negative cocci in the process of division. The figure also shows (15) and might interfere in an immunologic assay for detection of the 37-kDa antigen or antibodies to the antigen.
Since the newly identified antigen has a molecular mass of 37 kDa, it was originally thought that it may be homologous to the autolytic enzyme (amidase or N-acetylmuramoyl-Lalanine amidase) described by Howard and Gooder (20) and purified by Holtje and Tomasz (19) . The molecular mass of the amidase is 35 kDa. However, the anti-37-kDa MAbs did not inhibit the enzymatic activity of the amidase when tested, whereas polyvalent antiamidase serum did inhibit this activity (A. Tomasz, personal communication). To further test for similarity between the antigens, S. pneumoniae M31, a mutant strain described by Sanchez-Puelles et al. (34) findings provide evidence that the 37-kDa antigen described in this report is distinct from the 35-kDa amidase. Thus, strain M31 does not produce amidase but does produce an antigen that reacts with the MAbs.
The MAbs reacted with whole pneumococcus cells in an ELISA. Immunofluorescence of the bacteria in an IFA did not require any permeabilizing treatment of the pneumococcus cell before staining. Therefore, the determinants or epitopes to which the MAbs bind on the species-specific antigen appear to be exposed or partially exposed on the surface of the cell. The immunogold assay showed that the greater portion of the antibody-binding epitopes are located inside the pneumococcus cell. The antigen is probably synthesized inside the cell and leaches out to the surface. The ELISA and IFA results suggest the latter.
The species-specific antigen was found in all the S. pneumoniae isolates tested, including a mutant strain, M31, which was void of the autolytic enzyme. This antigen could therefore be a candidate for a pneumococcus vaccine, since protein antigens are usually more immunogenic in young children than are polysaccharide antigens. The antigen could also be used in the development of a diagnostic test for S. pneumoniae infections. Further studies to purify the 37-kDa antigen and determine its usefulness in an antibody capture assay are in progress.
